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1. Introduction 
The mammalian retina is a laminated sensorineural epithelium composed of six classes of 
neurons that include the rod, cone, bipolar, horizontal, amacrine, and ganglion cells (RGCs), 
and one type of glia, the Müller cells. RGCs are the sole output neurons in the retina whose 
projecting axons form the optic nerve essential for conveying light signals to the higher 
visual system in the brain. Glaucoma causes degeneration of the optic nerve and RGCs that 
leads to impaired vision and blindness. Recent advances in stem cell-based therapy to 
restore functional retinal circuits in the damaged retina have made it promising to develop 
an effective treatment of glaucoma in the future. It is conceivable that, in the future, RGCs 
derived through controlled differentiation of stem cells by various retinogenic factors may 
provide renewable sources of replacement RGCs for glaucoma patients. Because 
differentiation of stem cells normally recapitulates the events that occur during 
embryogenesis, it will be important to understand the molecular basis of RGC development 
and identify intrinsic and extrinsic factors involved in RGC fate determination and 
differentiation. 
In this chapter, we will summarize and discuss recent molecular genetic studies on intrinsic 
and extrinsic factors required for RGC development, and how they act to establish RGC 
competence, determine RGC fate and facilitate RGC differentiation (Fig. 1). We will also 
discuss gene regulatory networks governing RGC development as well as safeguard 
mechanisms ensuring RGC differentiation from multipotent retinal precursors. Finally, we 
will discuss how our knowledge about the intrinsic and extrinsic retinogenic factors may 
contribute to devising efficient means to generate RGCs from stem cells. Some of our own 
work will be highlighted throughout the chapter. 
2. Intrinsic factors 
2.1 Transcription factors involved in RGC fate and differentiation 
Pou4f/Brn3 factors. Our molecular cloning of the POU-domain transcription factor 
Pou4f2/Brn3b and demonstration of its expression in RGCs about two decades ago (Xiang 
et al., 1993) provided an entry point for the ensuing explosion of studies on the genetic  
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Fig. 1. Schematic illustration of developmental stages and intrinsic and extrinsic factors 
leading to RGC production from progenitors. Multiple transcription factors and signaling 
molecules are involved to drive progression from multipotent retinal progenitors to RGC 
competent precursors and to eventually specified and differentiated RGCs. The Atoh7-
expressing RGC precursors are also competent to generate amacrine, horizontal and cone cells 
 
 
Fig. 2. Expression patterns of Pou4f proteins during mouse retinogenesis. Retinal sections 
from the indicated stages were immunostained with anti-Pou4f1, anti-Pou4f2 and anti-
Pou4f3 antibodies. Pou4f2 commences its expression in occasional cells (indicated by the 
arrow head) of E11.5 retinas. At E12.5-E18.5, it is localized in a large number of cells in the 
ganglion cell layer (GCL), as well as in scattered cells (indicated by arrows) within the outer 
neuroblastic layer (ONBL). In postnatal retinas, Pou4f2 expression is restricted to the RGCs 
in the GCL. Pou4f1 and 3 are found only in cells of the GCL beginning at E13.5 
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pathway and gene regulatory network of RGC development. In vertebrates (from zebrafish 
to human), there exist three family members of Pou4f factors (Pou4f1-3 or Brn3a-c) and 
within the retina their expression is all confined to RGCs (DeCarvalho et al., 2004; Gerrero 
et al., 1993; Hutcheson and Vetter, 2001; Turner et al., 1994; Xiang et al., 1995; Xiang et al., 
1993). In the adult mouse retina, Pou4f1 and 2 are estimated to be localized in more than 
70% of RGCs whereas Pou4f3 in ~ 30% of total RGCs (Xiang et al., 1995). During mouse 
retinogenesis, the three Pou4f factors exhibit overlapping but spatiotemporally distinct 
expression patterns, with only Pou4f2 sporting a pattern characteristic of the dynamic 
profile of RGC genesis (Gan et al., 1996; Xiang, 1998). At prenatal stages, Pou4f2-
immunoreactive cells are seen at the time of first RGC birth at embryonic day 11.5 (E11.5) 
(Young, 1985), and in newborn migrating RGCs in the outer neuroblastic layer (Fig. 2F-J) 
(Gan et al., 1996; Xiang, 1998). The onset of Pou4f1 and 3 expression occurs two days later 
only in differentiated RGCs within the ganglion cell layer (Fig. 2A-E, K-O) (Xiang, 1998). 
Interestingly, there seems to be always one Pou4f factor whose spatiotemporal expression 
pattern follows closely with the timing of RGC generation in other vertebrates, such as 
cPou4f3/cBrn3c and XBrn3d, in the case of chicken and Xenopus, respectively (Hutcheson 
and Vetter, 2001; Liu et al., 2000a). This correlative early Pou4f expression suggested to us 
that Pou4f function might not only be required for RGC differentiation but also for an 
earlier role (Xiang, 1998), which we later showed to be in RGC fate specification (Qiu et al., 
2008). 
All three Pou4f genes were deleted in mice by gene targeting to study their developmental 
function (Erkman et al., 1996; Gan et al., 1999; Gan et al., 1996; McEvilly et al., 1996; Xiang et 
al., 1997; Xiang et al., 1996). Pou4f2 inactivation leads to optic nerve hypoplasia as well as 
thinner retinas with reduced thickness of the ganglion cell, nerve fiber and inner plexiform 
layers (Fig. 3A-C) (Gan et al., 1996). Pou4f2 mutant optic nerves are diminished in cross-
sectional area by approximately 5-fold and have a significantly reduced density of axons 
(Fig. 3D,E). The mutant retinas lose ~ 70-80% of total RGCs and exhibit a dramatic decrease 
in the number of Pou4f1- and Pou4f3-positive cells and Thy1- and SMI-32-immunoreactive 
processes (Fig. 3F-I) (Gan et al., 1996). These RGC defects occur early in development in the 
mutant (Fig. 3J-Q). Optic nerve hypoplasia, nerve fiber defasciculation, and diminished 
Pou4f1, Pou4f2, Ebf1, and Pou6f2/RPF-1 expression are visible as early as E12.5 (Gan et al., 
1999; Xiang, 1998). RGC axon guidance errors are also present at multiple intraocular and 
extraocular points along their projection pathways in developing and adult Pou4f2 null 
mutant mice (Erkman et al., 2000). Meanwhile, inactivating Pou4f2 appears to cause many 
presumptive RGC precursors to switch to amacrine or horizontal cell fates (Qiu et al., 2008). 
These improperly differentiated cells are likely to degenerate by apoptosis as cell death 
significantly increases in the mutant retina (Gan et al., 1999; Xiang, 1998). Thus, Pou4f2 plays 
an essential role in RGC differentiation as well as their fate specification. It was thought that 
Pou4f2 might be required only for RGC differentiation and survival because in Pou4f2lacZ/lacZ 
knockin retinas, normal number of β-gal(galactosidase)+ cells is initially produced that 
migrate into the inner neuroblastic layer (Gan et al., 1999). All of these β-gal+ cells were 
assumed to be RGCs but they were not confirmed as such using molecular markers. In fact, 
many cells within the inner neuroblastic layer of Pou4f2 null retinas extend short, 
microtubule-rich and nonfasciculated neurites characteristic of dendrites rather than axons 
(Gan et al., 1999; Wang et al., 2000). This phenotype may manifest a switch from RGCs to 
dendrite-bearing amacrine and horizontal cells even though a change of RGC cell polarity 
cannot be completely ruled out. 
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Fig. 3. Loss of RGCs in Pou4f2-/- retinas. (A,B) Semi-thin sections of wild-type (WT) and 
mutant retinas stained with toluidine blue. (C) Optic nerves of the wild-type and mutant 
mice. (D,E) Electron micrographs of wild-type and mutant optic nerves. (F-I) In wholemount 
retinas, nuclei in the ganglion cell layer were labeled with SYTOX (F,G) or immunostained 
with an anti-Pou4f1 antibody (H,I). (J-M) Thy1 immunoreactivity in sections of retinas from 
the indicated stages. (N-Q) E15.5 retinal sections were immunolabeled with anti-Pou4f1 
(N,O) or anti-Pou4f3 (P,Q) antibodies. In the adult Pou4f2-/- retina, there is a dramatic loss of 
RGCs as indicated by the reduced retinal thickness (A,B), diminished optic nerve diameter 
(C), decreased axon density within the optic nerve (D,E), and reduced cell number in the 
ganglion cell layer (F-I). The loss of RGCs immunoreactive for Thy1, Pou4f1 or Pou4f3 occur 
early in development in the mutant retina (J-Q). GCL, ganglion cell layer; INL, inner nuclear 
layer; IPL, inner plexiform layer; IS, inner segment; NFL, nerve fiber layer; ONBL, outer 
neuroblastic layer; on, optic nerve; ONL, outer nuclear layer; OPL, outer plexiform layer; 
OS, outer segment 
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Given that the three Pou4f factors are 95% identical in protein sequence of the DNA-binding 
POU domain and have similar DNA-binding specificity and transcriptional activity (Gruber 
et al., 1997; Liu et al., 2000a; Xiang et al., 1995), it is unsurprising that they display a 
significant degree of functional redundancy in RGC development. Thus, no obvious RGC 
defects are found in Pou4f1 and 3 conventional knockout mice despite the presence of other 
severe sensory deficiency (Xiang et al., 1997; Xiang et al., 1996). Moreover, there are more 
severe RGC loss and axon growth defects in Pou4f2 and 3 compound mutant mice (Wang et 
al., 2002). We speculate that Pou4f2 can largely take over the function of Pou4f1 and 3 due to 
its early expression whereas the converse is not true because the belated expression of 
Pou4f1 and 3 precludes them from compensating an early specification/differentiation role 
of Pou4f2 (Xiang, 1998). Consistent with this notion, when Pou4f1 was knocked in the Pou4f2 
locus to ensure its early expression, all phenotypes associated with Pou4f2 inactivation were 
apparently completely rescued (Pan et al., 2005). In spite of the extensive overlap in 
expression and function, however, individual Pou4f factors have distinct roles during RGC 
development. For instance, conditional deletion of Pou4f1 changes dendritic morphology 
and stratification of RGCs, increases the ratio of bistratified to monostratified RGCs, and 
causes modest RGC loss (Badea et al., 2009; Badea and Nathans, 2011). Although conditional 
inactivation of Pou4f2 results in similar defects, it causes no alteration in RGC dendritic 
stratification but additionally leads to RGC transdifferentitation and central projection 
defects (Badea et al., 2009; Badea and Nathans, 2011). However, conditional Pou4f3 mutants 
lack any of these RGC phenotypes (Badea and Nathans, 2011). 
Pou4f2 is not only necessary but also sufficient to promote RGC differentiation from retinal 
progenitors. In mouse embryonic retinas, misexpressed Pou4f2 dramatically increased 
Pou4f1-positive RGCs (Qiu et al., 2008). When misexpressed in chick retinal progenitors by 
the replication-competent RCAS retroviral vector, mouse Pou4f2 increased cells 
immunoreactive for Isl1 and NF200, two RGC markers, by 20-50% (Fig. 4C,D,L) (Liu et al., 
2000a). Forced expression of mouse Pou4f1 and Pou4f3 as well as chicken Pou4f3 (cPou4f3) 
all similarly promoted RGC differentiation (Fig. 4M,N) (Liu et al., 2000a), suggesting that all 
Pou4f factors have a similar potential to promote RGC development but this potential may 
be limited by their order of expression in vivo. Moreover, misexpression of each of the three 
mouse Pou4f factors induced many cells to express cPou4f3 in the outer neuroblastic layer 
(Fig. 4G-I) (Liu et al., 2001). No cPou4f3-positive cells were induced when a mutant Pou4f3 
protein was ectopically expressed that contained a deletion in the POU-homeodomain 
(Fig. 4J) (Liu et al., 2001). Therefore, Pou4f gene expression may be cross-activated and auto-
activated to help maintain their expression necessary for RGC specification and 
differentiation (Fig. 4O). Nevertheless, other mechanisms must operate to maintain Pou4f1 
and 2 expression since inactivating either gene in mice does not completely abolish the 
expression the other in RGCs (Badea et al., 2009; Gan et al., 1996; Xiang et al., 1996). In this 
regard, the Isl1 LIM-homeodomain transcription factor appears to play a role in the 
maintenance of Pou4f2 expression (Mu et al., 2008; Pan et al., 2008). 
Pou4f2 regulates a large set of downstream genes to fulfill its crucial function in RGC 
specification and differentiation. Microarray gene expression profiling of Pou4f2 wild-type 
and mutant retinas has revealed hundreds of genes whose expression is altered in the 
mutant (Mu et al., 2004; Qiu et al., 2008). Among the downregulated genes are those 
encoding transcription factors and proteins involved in morphogenesis, nervous system 
development, neuronal cell projection, synaptic vesicle, and neurofilament, consistent with 
the role of Pou4f2 in RGC development. In particular, Pou4f2 activates the expression of Shh 
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Fig. 4. Regulatory relationship between Atoh7 and Pou4f factors and effects of misexpressed 
Atoh7 and Pou4f factors on RGC production in the chick retina. (A,B) In the outer neuroblastic 
layer (ONBL) of E11.5 flat-mount retinas infected with RCAS-cAtoh7 viruses, there was a 
significant increase of cPou4f3-immunoreactive cells compared to the control (RCAS-AP). 
(C,D) Adjacent sections from an E7.5 retina infected with RCAS-Pou4f2 viruses were 
immunostained with anti-p27 gag (C) or anti-Isl1 (D) antibodies. More Isl1-immunoreactive 
cells were found in the patch stained with the anti-p27 gag antibody than in the patch negative 
for it. (E-J) Sections from intermediate regions of E11.5 control retinas and retinas infected 
with RCAS-Atoh7, RCAS-Pou4f1, RCAS-Pou4f2, RCAS-Pou4f3, or RCAS-Pou4f3∆8 viruses 
were immunostained with an anti-cPou4f3 antibody. Misexpressed Atoh7, Pou4f1, Pou4f2, 
and Pou4f3 caused a significant increase of cPou4f3 immunoreactive cells in the ONBL, 
whereas misexpressed Pou4f3∆8 had no effect. (K-N) Quantitation of cPou4f3-, Isl1- or NF200-
positive RGCs in retinas infected with RCAS-Atoh7, RCAS-Pou4f2, RCAS-Pou4f1, or RCAS-
Pou4f3 viruses. (O) Schematic illustrating regulatory relationship between Atoh7 and Pou4f 
factors during RGC development. Atoh7 may directly activate Pou4f2 expression which in 
turn may activate the expression of Pou4f1 and Pou4f3. Pou4f gene expression may be cross-
activated and auto-activated to help maintain their expression. GCL, ganglion cell layer 
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(sonic hedgehog) signal pathway genes (Mu et al., 2004). On the other hand, Pou4f2 is also 
required to repress many genes involved in non-RGC generation to ensure faithful 
differentiation of RGCs (Qiu et al., 2008). 
Isl1. Isl1 resembles Pou4f2 in many ways in controlling RGC development. During mouse 
retinogenesis, it is co-expressed with Pou4f2 in migrating newborn RGCs beginning at E11.5 
(Pan et al., 2008). Conditional inactivation of Isl1 results in optic nerve hypoplasia, a loss of 
~70% of RGCs, delayed RGC axon growth, and RGC axon pathfinding errors and fiber 
defasciculation (Mu et al., 2008; Pan et al., 2008). Further RGC loss is seen in Pou4f2 and Isl1 
compound null mice (Pan et al., 2008), implicating distinct as well as redundant functions 
between Pou4f2 and Isl1 during RGC development. Indeed, these two factors regulate 
overlapping but distinct groups of genes and they co-occupy the promoters of several 
shared RGC genes (Mu et al., 2008; Pan et al., 2008). Isl1 does not act genetically upstream of 
Pou4f2 since its absence does not alter Pou4f2 expression in early embryonic retinas (Mu et 
al., 2008). However, it is unclear whether Isl1 acts only in parallel with Pou4f2 or 
additionally downstream of it to control RGC differentiation. 
Dlx1 & Dlx2. The Dlx1 and 2 homeodomain transcription factors are also co-expressed with 
Pou4f2 in developing RGCs during mouse retinal development (de Melo et al., 2003). Their 
compound mutants display a mild optic nerve hypoplasia, a loss of ~ 30-40% of RGCs, and 
increased apoptosis (de Melo et al., 2005). The RGC loss in double mutants results from 
decreased generation of late born RGCs, thereby indicating a critical role for Dlx1 and 2 in 
differentiation of late-born RGCs (de Melo et al., 2005). Because these two factors normally 
repress the expression of a photoreceptor marker Crx (de Melo et al., 2005), it is possible that 
they may also have a role in specifying late-born RGCs. 
Eomes & Ebf factors. These factors act as Pou4f2 effectors to mediate part of Pou4f2 
function during RGC development. Their genes are among the most downregulated in 
Pou4f2 null retinas as determined by microarray analysis (Qiu et al., 2008). Eomes is a T-box 
transcription factor that similar to Pou4f1 and 3, is expressed in developing RGCs only upon 
their arrival into the RGC layer (Mao et al., 2008). Its expression is directly activated by 
Pou4f2 through a 5’ enhancer and is completely downregulated in Pou4f2 null retinas (Mao 
et al., 2008). Conditional inactivation of Eomes causes a 30% decrease in RGC number and 
optic nerve size, reduced and disorganized RGC axon myelination, and increased apoptosis 
(Mao et al., 2008). Ebf1-4 belong to a small family of HLH (helix-loop-helix) transcription 
factors that are selectively expressed in RGCs in mouse embryonic retinas (Fig. 5A) (Jin et 
al., 2010). Their RGC expression is dramatically downregulated in Pou4f2 null mutants (Fig. 
A-D). It appears that Pou4f2 can bind to the promoter of Ebf3 to directly activate its 
expression (Jin et al., 2010). To investigate a possible role for Ebfs during RGC development, 
we used a replication-incompetent retroviral vector that carries a GFP reporter to 
misexpress Ebf1 and Ebf-EnR, a dominant-negative form of Ebf constructed by fusing the 
repressor domain of the Drosophila-engrailed protein to the Ebf1 N-terminus. We infected 
mouse retinal explants with Control-GFP, Ebf1-GFP or Ebf-EnR-GFP viruses at E13.5 when 
progenitors are still competent for producing RGCs. The infected retinas were harvested 
after 4 days in culture to analyze RGC production. We found that forced Ebf-EnR expression 
reduced the proportion of Pou4f1- and Pou4f2-immunoreactive RGCs by ~40-50%, whereas 
Ebf1 exerted no effect on them (Fig. 5E-K) (Jin et al., 2010). Thus, Ebfs are necessary but 
insufficient to promote RGC differentiation. It is unknown whether Eomes is sufficient to 
promote RGC formation as there is yet no report of pertinent gain-of-function analysis. 
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Fig. 5. Requirement for Ebf factors in RGC differentiation. (A-D) Retinal sections from wild-
type (WT) and Pou4f2-/- mice at the indicated stages were immunostained with a pan-Ebf 
antibody and weakly counterstained with nuclear DAPI. In the mutant retina, there is a 
dramatic decrease of Ebf-immunoreactive cells within the INBL or GCL. (E-K) Effect of Ebf1 
and a dominant-negative Ebf misexpressed in E13.5 mouse retinal explants on the formation 
of RGCs. Sections from retinas infected with Control-GFP, Ebf1-GFP or Ebf-EnR-GFP 
viruses were double immunostained with an anti-GFP antibody and antibodies against 
Pou4f1 or Pou4f2 (E-J). Virus-transduced retinal cells that became immunoreactive for 
Pou4f1 or Pou4f2 were then quantified (K, each histogram represents the mean±SD for three 
retinas). Misexpressed wild-type Ebf1 does not change the number of RGCs immunoreactive 
for Pou4f1 or Pou4f2; whereas, the dominant-negative form diminishes cells immunoreactive 
for them. Arrows point to representative colocalized cells, and insets show corresponding 
outlined regions at a higher magnification. GCL, ganglion cell layer; INL, inner nuclear 
layer; INBL, inner neuroblastic layer; IPL, inner plexiform layer; ONBL, outer neuroblastic 
layer; ONL, outer nuclear layer; OPL, outer plexiform layer 
2.2 Transcription factors involved in RGC competence 
Prior to the initiation of retinogenesis, neuroepithelial cells in the optic vesicle must acquire 
multipotency and establish competence for the generation of the full range of retinal cell 
types. Pax6, a paired homeodomain transcription factor, and Sox2, a HMG-box transcription 
factor, appear to coordinately regulate multipotency of retinal progenitor cells including the 
potency to generate RGCs. Conditional ablation of either gene in mouse retinal progenitors 
results in a failure to produce RGCs and other non-RGC cell types (Marquardt et al., 2001; 
Taranova et al., 2006). Retinal progenitors are postulated to undergo a series of successive 
stages of competence for the ordered generation of different cell types (Cepko, 1999; Cepko 
et al., 1996; Harris, 1997; Livesey and Cepko, 2001). It has been shown that the Ikaros zinc 
finger transcription factor plays a key role in establishing the early temporal competence 
stages responsible for generating early-born cell types including RGCs (Elliott et al., 2008). 
Inactivating Ikaros causes decreased numbers of early-born neurons without affecting late-
born cell types whereas its misexpression in postnatal retinal progenitors is sufficient to 
confer them with prenatal competence to generate early-born cell types (Elliott et al., 2008). 
Pax6, Sox2 and Ikaros all directly and/or indirectly activate Atoh7/Math5 expression to 
confer progenitors with the competence of RGC genesis (Fig. 1), as genetic ablation of any of 
these three genes leads to loss or decreased Atoh7 expression (Elliott et al., 2008; Marquardt 
et al., 2001; Taranova et al., 2006). 
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Atoh7 is a proneural bHLH (basic helix-loop-helix) transcription factor expressed transiently 
in a subset of retinal progenitors/precursors (Brown et al., 1998; Kanekar et al., 1997; Liu et 
al., 2001). Misexpression of Xenopus Atoh7 (Xath5) in retinal progenitors promoted RGC 
differentiation by ~ 3-fold at the expense of amacrine, bipolar and Müller cells (Kanekar et 
al., 1997). We used the RCAS retroviral vector to overexpress chicken Atoh7 (cAtoh7/Cath5) 
in chick retinal progenitors and found that forced cAtoh7 expression significantly induced 
the expression of cPou4f3, a functional equivalent of Pou4f2 in the chick retina (Fig. 4A,B) 
(Liu et al., 2001). It increased RGCs immunoreactive for cPou4f3, Isl1 or NF200 by ~30-60% 
(Liu et al., 2001). Similarly, forced expression of mouse Atoh7 induced cPou4f3 expression 
and significantly promoted the differentiation of RGCs expressing Isl1 and NF200 in the 
developing chick retina (Fig. 4F,K). Furthermore, Atoh7 from both mouse and chicken was 
able to activate reporter gene expression through a Pou4f2 promoter (Liu et al., 2001). 
Because all Pou4f factors have the ability to promote RGC formation (Liu et al., 2000a), our 
results demonstrate that Atoh7 can promote RGC differentiation by directly activating 
Pou4f2/cPou4f3 expression, and further define an Atoh7-Pou4f2/cPou4f3 pathway 
underlying the specification and differentiation of RGCs (Fig. 4O) (Liu et al., 2001). This 
molecular pathway can be confirmed in Atoh7 knockout mice by the near complete 
downregulation of Pou4f2 expression in Atoh7 mutant retinas (Wang et al., 2001). 
Consistent with the gain-of-function studies, loss-of-function analyses in zebrafish and mice 
have confirmed an essential role for Atoh7 in RGC development. Its mutation in the 
zebrafish lakritz mutant causes a complete loss of RGCs and its deletion in mice results in the 
absence of optic nerve and a loss of ~95% of RGCs (Brown et al., 2001; Kay et al., 2001; Wang 
et al., 2001). The virtual absence of Pou4f2-expressing cells in early Atoh7 mutant retinas 
suggests that Atoh7 must have an early role during RGC development. However, a role for 
Atoh7 in RGC fate specification can be ruled out because genetically marked Atoh7-
expressing precursors are found to give rise to multiple early-born retinal cell types 
including RGC, amacrine, horizontal and photoreceptor cells (Yang et al., 2003). Therefore, 
Atoh7-positive retinal precursors are multipotential and Atoh7 is required only for 
conferring these precursors with the competence of RGC generation. In agreement with this 
early function, microarray gene expression profiling analysis has revealed that Atoh7-
regulated genes include the two branches of genes controlled by Pou4f2 and Isl1 and 
additionally contain many more that are not regulated by either factor (Mu et al., 2005). 
Moreover, Atoh7 and Pou4f2 double knockout mice display more severe loss of RGCs 
(Moshiri et al., 2008). Wt1, a zinc-finger transcription factor encoded by the Wilms’ tumor 
gene, appears to regulate RGC differentiation also by directly activating Pou4f2 expression 
(Wagner et al., 2002). However, it is unclear what is the relationship between Wt1 and Atoh7 
and whether Wt1 is involved in conferring retinal precursors with RGC competence. 
2.3 Safeguard mechanism by transcription factors to ensure RGC fidelity 
As discussed above, RGC-competent Atoh7+ precursors are able to generate RGC, amacrine, 
horizontal, and cone photoreceptor cells during mouse retinogenesis (Fig. 1) (Feng et al., 
2006; Yang et al., 2003). Thus, in order to select the RGC fate from the multiple fates 
available for an RGC-competent precursor, it is conceivable that the commitment factor 
must suppress non-RGC fates while promoting the RGC fate to ensure the fidelity of RGC 
differentiation. In this regard, we have demonstrated that Pou4f2 has the ability to suppress 
amacrine, horizontal and late-born RGC fates to preferentially specify the early-born RGC 
fates (Qiu et al., 2008) 
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In E14.5 Pou4f2 null retinas, our gene expression profiling study identified a large set of 
upregulated genes including Th, Slc32a1/VIAAT, Slc6a1/GAT-1, Slc18a3/VAChT, and 
Gad1/GAD67, which are normally expressed by amacrine and/or horizontal cells (Qiu et al., 
2008). Consistent with this, immunostaining and RNA in situ hybridization revealed a 
marked increase in the expression of Th, GABA, GAT-1, calbindin D28K, and Viaat in the 
mutant retina (Fig. 6A-F) (Qiu et al., 2008), suggesting that GABAergic amacrine cells 
abnormally form in early embryonic retinas in the absence of Pou4f2. In Pou4f2lacZ/lacZ retinas, 
nearly all Th-immunoreactive cells were co-labeled for β-gal (Fig. 6B), indicating that these 
cells arise cell-autonomously due to a switch in fate of RGC precursors that would normally 
express Pou4f2. Double-immunostaining showed a significant increase of cells 
immunoreactive for both Lim1 and calbindin in Pou4f2 null retinas (Fig. 6E,F), suggesting 
that loss of Pou4f2 function causes increased horizontal cell differentiation. These 
supernumerary horizontal cells also arise cell-autonomously because in Pou4f2lacZ/lacZ retinas, 
many Lim1-immunoreactive cells co-expressed β-gal whereas these double-immunoreactive 
cells were absent from Pou4f2+/lacZ retinas (Qiu et al., 2008). The transcripts of Dlx1 and Dlx2 
were among the most upregulated in Pou4f2 null retinas as determined by microarray 
analysis. At E14.5, scattered in situ hybridization signals for Dlx1 and Dlx2 were seen in the 
outer neuroblastic layer but absent from the inner neuroblastic layer (INBL) of wild-type 
retinas (Fig. 6Q,S). In Pou4f2-/- retinas, however, both Dlx1 and Dlx2 were aberrantly 
expressed within the INBL (Fig. 6R,T), suggesting the generation of superfluous late-born 
RGCs within the INBL in the absence of Pou4f2. Thus, Pou4f2 has the activity to cell-
autonomously inhibit differentiation of amacrine, horizontal and late-born RGCs. This 
inhibitory activity can be confirmed by overexpression experiments where we showed that 
misexpressed Pou4f2 suppressed the differentiation of all non-RGC cell types including 
amacrine and horizontal cells (Qiu et al., 2008). 
Pou4f2 acts to inhibit the fates of non-RGCs by repressing the expression of transcription 
factor genes required for their specification and differentiation. By microarray analysis, in 
situ hybridization, qRT-PCR, and immunostaining, we were able to show that the 
expression of Bhlhb5, Nr4a2/Nurr1, Neurod1, Math3, and Ptf1a all exhibited significant 
increase in Pou4f2 null retinas, especially within the INBL (Fig. 6G-L) (Qiu et al., 2008), 
consistent with the abnormal differentiation of most amacrine cells in this layer of the 
mutant retina. It has been shown that Neurod1, Math3 and Ptf1a are required for specifying 
amacrine cells and Bhlhb5 and Nr4a2 for differentiation of GABAergic amacrine cells (Feng 
et al., 2006; Fujitani et al., 2006; Inoue et al., 2002; Jiang and Xiang, 2009; Nakhai et al., 2007). 
Similarly, there was a significant increase in expression of Prox1, Ptf1a, Lim1 and Ngn2, all 
transcription factor genes involved in horizontal cell development (Akagi et al., 2004; Dyer 
et al., 2003; Fujitani et al., 2006; Liu et al., 2000b; Nakhai et al., 2007; Poche et al., 2007), 
within the INBL of Pou4f2 null retinas (Fig. 6E,F,M-P). In addition, we observed in Pou4f2-/- 
retinas a moderate but significant increase in the expression of Otx2, Crx, Thrb2 and 
Prdm1/Blimp1 (Qiu et al., 2008), which are all transcription factor genes involved in 
photoreceptor cell development (Brzezinski et al., 2010; Furukawa et al., 1997; Furukawa et 
al., 1999; Ng et al., 2001; Nishida et al., 2003; Wilm and Solnica-Krezel, 2005).These studies 
have led us to propose that while promoting the differentiation of early-born RGCs, Pou4f2 
may actively suppress the differentiation of late-born RGC, amacrine, horizontal, and cone 
cells by repressing a network of transcription factor genes involved in their commitment 
and differentiation (Fig. 7A) (Qiu et al., 2008). This built-in negative regulatory program 
may serve as a safeguard mechanism to ensure the differentiation of all Pou4f2-expressing 
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precursors as early-born RGCs, thereby guaranteeing the fidelity of RGC differentiation. In 
the absence of Pou4f2, the release of the safeguard mechanism may cause RGC precursors to 
change their cell fates and abnormally generate amacrine, horizontal and late-born RGC 
cells that may ultimately degenerate by apoptosis (Fig. 7B). In spite of the apparent 
inhibition of late-born RGC fates, it is still possible that Pou4f2 may be involved in terminal 
differentiation of late-born RGCs given the crucial role of Pou4f2 in RGC differentiation and 
the co-expression between Pou4f2 and Dlx1/2 (de Melo et al., 2003). 
 
 
Fig. 6. Aberrant differentiation of amacrine, horizontal and ganglion cells in Pou4f2 null 
mutant retinas. (A-H) Retinal sections at the indicated stages from Pou4f2+/lacZ (A,E,G), 
Pou4f2lacZ/lacZ (B,F,H), Pou4f2+/- (C), and Pou4f2-/- (D) embryos were immunostained with the 
indicated antibodies. Within the INBL of null retinas, there was a significant increase of 
GABA-immunoreactivity and cells double-immunoreactive for Lim1 and calbindin or β-gal 
and Th or Neurod1 (indicated by arrows). (I-T) Retinal sections at the indicated stages from 
Pou4f2+/+ (K,M,O,Q,S), Pou4f2+/- (I), and Pou4f2-/- (J,L,N,P,R,T) embryos were in situ hybridized 
with the indicated RNA probes. Within the INBL of null retinas, there was a significant 
increase in expression of Bhlhb5, Nr4a2, Ngn2 (indicated by arrowheads), Prox1 (indicated by 
arrowheads), Dlx1, and Dlx2. INBL, inner neuroblastic layer; ONBL, outer neuroblastic layer 
Despite the comprehensive negative regulatory program, Pou4f2 appears to suppress 
photoreceptor or glycinergic amacrine cell fates only weakly or not at all (Qiu et al., 2008), 
raising the possibility that it may have to cooperate with other regulatory factors to inhibit 
all other alternative cell fates available to a particular RGC precursor. Targeted Atoh7 
inactivation leads to increased cones and cholinergic amacrine cells (Brown et al., 2001; 
Wang et al., 2001), thereby indicating an inherent activity for Atoh7 to suppress cone and 
cholinergic amacrine cell fates even though the precursors expressing it are able to produce 
both cell types (Yang et al., 2003). Conceivably, Pou4f2 may cooperate with Atoh7 to ensure 
complete suppression of the amacrine and cone differentiation programs in RGC precursors. 
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Similar to Pou4f2, Atoh7 appears to repress the expression of Neurod1, Math3, Bhlhb5, and 
Ngn2 to suppress the amacrine and/or horizontal cell fates (Feng et al., 2006; Mu et al., 
2005). Although it remains to be determined whether Atoh7 also represses the expression of 
photoreceptor transcription factor genes, it seems that Pou4f2 and Atoh7, and likely other 
RGC transcription factors, may all have built-in safeguard mechanisms that only when 
working together can ensure the highest fidelity of RGC differentiation. 
 
 
Fig. 7. Schematics illustrating the safeguard mechanism by which Pou4f2 specifies early-
born RGCs. (A) RGC-competent Atoh7+ precursors are able to generate early-born and late-
born RGCs and amacrine, horizontal and cone cells. When Pou4f2 is expressed in such a 
multipotential precursor, it commits it to an early-born RGC fate while preventing it from 
following other differentiation pathways by repressing the expression of a network of 
retinogenic transcription factor genes involved in fate commitment and differentiation of 
late-born RGC, amacrine, horizontal, and cone cells. (B) When expressed in RGC-competent 
precursors, Pou4f2 specifies early-born RGCs and promotes their differentiation in wild-type 
retinas. In the Pou4f2 mutant, the safeguard mechanism is compromised and the precursors 
that would normally express Pou4f2 switch their fates to aberrantly produce late-born RGC, 
amacrine and horizontal cells that would quickly degenerate by apoptosis. A small portion 
of early-born RGCs may be produced due to functional compensation by Pou4f1 and Pou4f3 
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3. Extrinsic signaling 
During retinal development, RGC generation initiates near the center of the developing 
retina and then propagates toward the periphery in a wave-like fashion (McCabe et al., 1999; 
Neumann and Nuesslein-Volhard, 2000). It has been shown that fibroblast growth factor 3 
(FGF3) and FGF8 secreted from local organizing centers act together to induce the first wave 
of RGC differentiation from retinal progenitors (Martinez-Morales et al., 2005). FGF8 
released from coated beads promotes Atoh7 expression and triggers RGC differentiation 
whereas pharmacological inhibition of FGF signaling blocks Atoh7 expression and RGC 
differentiation (Martinez-Morales et al., 2005). In zebrafish deficient for both Fgf3 and Fgf8, 
Atoh7 expression fails to initiate in the developing retina (Martinez-Morales et al., 2005). 
Indeed, FGF signaling activates Xenopus Atoh7 gene expression through its 5’ regulatory 
sequence (Willardsen et al., 2009). FGF signaling may cooperate with Shh to coordinate the 
subsequent spread of RGC differentiation wave front. FGF19, via regulation of the Pea3 and 
Erm Ets-domain transcription factor genes, together with Shh released from new born RGCs, 
are required for propagation of Shh own gene expression (McCabe et al., 2006; Vinothkumar 
et al., 2008). Mutations in Shh signaling components and cyclopamine treatment all disrupt 
normal propagation of Shh and Atoh7 expression as well as RGC differentiation (Neumann 
and Nuesslein-Volhard, 2000; Stenkamp and Frey, 2003). FGF and Shh appear to activate the 
Ras-MAPK pathway to trigger and drive the wave of RGC differentiation (Neumann and 
Nuesslein-Volhard, 2000). Despite these compelling evidence in support of sequential 
induction of RGCs, other studies suggest that the progression of RGC differentiation wave 
may be governed by a dominant intrinsic mechanism pre-programmed into the progenitors 
(Kay et al., 2005). 
In contrast to the crucial requirement of Shh signaling in RGC differentiation progression, 
Shh secreted by new born RGCs behind the neurogenesis wave front prevents progenitors 
from generating more RGCs, thereby ensuring a proper number of total RGCs to be 
produced in the retina. In the chick retina, Shh overexpression decreases RGC production 
whereas inhibiting endogenous Shh activity increases RGC differentiation (Zhang and Yang, 
2001). Similarly, conditional ablation of Shh and Smoothened (Smo) in mice results in Atoh7-
dependent overproduction of RGCs (Sakagami et al., 2009). VEGF (vascular endothelial 
growth factor) is also secreted by RGCs and other postmitotic neurons and can negatively 
regulate RGC differentiation (Hashimoto et al., 2006). Thus, RGC formation is reduced by 
enhanced VEGF signals but increased by disrupting VEGF signaling activity (Hashimoto et 
al., 2006). Besides these diffusible signals, Dll-Notch signaling mediated by cell-cell contacts 
also limits RGC production. Constitutively activated Notch and elevated Dll signal are 
shown to decrease RGC generation whereas inhibiting Notch signaling has the opposite 
effect (Ahmad et al., 1997; Austin et al., 1995; Dorsky et al., 1997; Dorsky et al., 1995; Nelson 
et al., 2007). Interestingly, both Shh and VEGF signaling activates expression of the Dll-
Notch effector gene Hes1, which has an activity to suppress RGC differentiation (Hashimoto 
et al., 2006; Sakagami et al., 2009; Wang et al., 2005). Therefore, these divergent signaling 
pathways appear to converge on Hes1 to control proper RGC production during 
retinogenesis (Hashimoto et al., 2006). 
In the mouse retina, inactivation of the Gdf11 gene, which encodes a member of the TGF-
β/activin protein family, causes an increase of RGC production from progenitors whereas 
inactivating the follistatin gene, its antagonist, reduces RGCs (Kim et al., 2005). On the other 
hand, treating embryonic retinal explants with Gdf11 in culture results in a decrease of 
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RGCs. Neither Gdf11 nor follistatin exert any effect on the proliferation of retinal 
progenitors (Kim et al., 2005). Therefore, follistatin appears to increase the number of 
progenitors competent for RGC generation whereas Gdf11 antagonizes this activity, thereby 
contributing to a balanced production of RGCs. Gdf11 and follistatin control retinal 
progenitor competence by shortening and elongating the duration of Atoh7 expression, 
respectively (Kim et al., 2005). 
4. Generation of RGCs from stem cells 
As potential renewable sources of replacement cells for cell transplantation/replacement 
treatment, stem cells offer exciting future possibilities to restore functional retinal circuits in 
patients inflicted with retinal degeneration such as glaucoma (Dahlmann-Noor et al., 2010; 
Klassen et al., 2004; Lamba et al., 2008; MacLaren et al., 2006). It appears that the intrinsic 
and extrinsic mechanisms utilized to generate RGCs during normal development are 
recruited to stimulate RGC differentiation from stem cells both in vivo and in vitro. In the 
post-hatch chicken retina, FGF signaling is required to induce Atoh7 expression and 
subsequent production of Pou4f1- and Isl1-immunoreactive RGCs from stem cells in the 
ciliary marginal zone (Fischer et al., 2002). Similarly, mouse embryonic stem (ES) cells can be 
induced to generate RGC-like cells that express Atoh7, Pou4f2 and Isl1 only when exposed 
to FGF2, and this RGC-inducing activity by FGF2 is further potentiated by Shh (Jagatha et 
al., 2009). In rat retinal progenitors, transient expression of the intrinsic factor Atoh7 led to 
Pou4f2 upregulation and RGC induction (Yao et al., 2007). Pluripotent stem (iPS) cells 
induced from mouse fibroblasts can be also directed to form retinal progenitors that are 
capable of differentiating into RGC-like cells in the presence of suitable extrinsic and 
intrinsic cues. They produced RGCs expressing a variety of RGC-specific markers when 
cultured in retinal differentiation medium containing conditioned medium from E14 rat 
retinal cells (Parameswaran et al., 2010). These induced RGCs were able to extend processes 
toward superior collicular explants and exhibited typical neuronal activity (Parameswaran 
et al., 2010). Similarly, overexpression of Atoh7 could direct the iPS-derived retinal 
progenitors toward a RGC differentiation program, which could be further enhanced by 
inhibiting Notch signaling activity (Chen et al., 2010). Conceivably, application of a 
combination of stimulatory intrinsic and extrinsic factors while suppressing negative ones 
may lead to even greater induction of RGCs from stem cells. Transplanting in vitro induced 
retinal progenitors and RGCs intravitreally into postnatal rodent eyes resulted in only few 
cells that integrated into the RGC layer of the host retina (Chen et al., 2010; Jagatha et al., 
2009), suggesting that postnatal retinas present a formidable barrier to cell migration and 
integration. 
5. Summary and perspectives 
Great strides have been made over the past two decades toward understanding both the 
intrinsic and extrinsic mechanisms of RGC specification and differentiation from retinal 
progenitors. Molecular genetic studies coupled with bioinformatic approaches have yielded 
a wealth of information about transcription factors and their regulatory gene networks as 
well as signaling events that lead to the establishment of RGC competence and eventual 
differentiation of RGCs (Fig. 1). Significant inroads have also been made toward 
understanding the molecular basis underlying the fidelity of RGC differentiation and 
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production of proper number of RGCs. Despite these exciting advances, however, there are 
still many questions remaining to be answered. For instance, how do intrinsic and extrinsic 
factors interact and cooperate at cellular and transcriptional levels to drive RGC 
development and ensure proper RGC number? How do Atoh7 and Pou4f2 activate RGC 
differentiation program genes while repressing non-RGC differentiation program genes at 
the molecular level and what are their direct targets? What factors are responsible for 
specifying the extremely diverse RGC subtypes? What factors are required to efficiently 
induce RGCs from stem cells and what prevents them from migrating and integrating into 
the intact retina? Progress in these areas will undoubtedly lead to many more exciting 
discoveries in years to come. Ultimately, understanding the molecular events and factors 
involved in RGC development may lay the groundwork to improve stem cell-mediated 
regeneration, leading to eventual development of effective treatments of glaucoma in the 
future. 
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